High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers

  1. Steffen Fredersdorf*,
  2. Jorges Burns,
  3. Alistair M. Milne,
  4. Graham Packham*,
  5. Lynn Fallis*,
  6. Cheryl E. Gillett§,
  7. Janice A. Royds,
  8. David Peston,
  9. Peter A. Hall,
  10. Andrew M. Hanby§,
  11. Diana M. Barnes§,
  12. Sami Shousha,
  13. Mike J. O’Hare, and
  14. Xin Lu*,**
  1. *Ludwig Institute for Cancer Research, Imperial College School of Medicine at St. Mary’s, Norfolk Place, London, W2 1PG, United Kingdom; Ludwig Institute for Cancer Research, Courtauld Building, 91 Riding House Street, London, W1P 8BT, United Kingdom; Department of Molecular & Cellular Pathology, University of Dundee, Dundee, DD1 9SY, United Kingdom; §Clinical Oncology Unit, Imperial Cancer Research Fund, Guy’s Hospital, London, SE1 9RT, United Kingdom; Department of Pathology, University of Sheffield Medical School, Beech Hill Road, Sheffield, S10 2RX, United Kingdom; and Department of Histopathology, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, United Kingdom

Abstract

The expression of cyclin-dependent kinase inhibitor p27kip1 in human tumors and normal tissues was investigated using a panel of novel anti-p27kip1 mAbs. An inverse correlation between expression of p27kip1 and cell proliferation was generally observed after analyzing its expression in 25 different normal human tissues. In some highly proliferative human breast cancer cells, however, high level p27kip1 expression was seen, indicating the existence of a mechanism by which some growing tumor cells may tolerate this inhibitor of cell cycle progression. Detailed studies demonstrated a correlation between the high level expression of p27kip1 and cyclin D1 in human breast cancer cells. There was also an inverse correlation between the expression of p27kip1 and the degree of tumor malignancy in human breast and colorectal cancers, indicating that p27kip1 may be a useful prognostic marker in these cancers.

Footnotes

  • ** To whom reprint requests should be addressed.

  • Walter Bodmer, Imperial Cancer Research Fund, Oxford, United Kingdom

  • ABBREVIATION:
    GST,
    glutathione S-transferase
« Previous | Next Article »Table of Contents